Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria
Titel:
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria
Auteur:
POLLMANN, H. EXTERNEST, D. GANSER, A. EIFRIG, B. KREUZ, W. LENK, H. PABINGER, I. SCHRAMM, W. SCHWARZ, T. F. ZIMMERMANN, R. ZAVAZAVA, N. OLDENBURG, J. KLAMROTH, R.